Sonia Chaliha is head of Sales and Relationship Management for the Latin American and Canadian Corporate Trust businesses covering cross border transactions coming into the U.S. markets from these regions, as well as management of a domestic Canadian business, BNY Trust Company of Canada. Previously, Sonia’s remit also included domestic businesses in both Mexico (operating as regulated Bank entity) and Brazil; in 2014, she sold the Mexican business to another local financial institution and also realigned the local Brazilian business into Asset Servicing Brazil. Sonia is the Chairman of the Board for BNY Trust Company of Canada and held equivalent directorship for the Mexican Bank entity.
Prior to her current role, Sonia was the QSR London Business Manager, a Corporate Trust business that specialized in providing consultative and administrative services to the structured finance market globally. Immediately prior to her move to the US in 2009, Sonia led the negotiation and onboarding of US government stabilization initiatives into the firm, including TALF, Maiden Lane I & II, Straight A Funding and the Public-Private Investment Programme (PPIP) as well as other major, market based workouts and restructurings in the US, Europe and Canada.
Sonia came to BNY Mellon as a result of an acquisition of part of Quadrant Capital Limited in 2002, a UK-based investment management firm (formerly Singer & Friedlander Capital Markets Limited) where she had been since 1997. Sonia’s prior experience spans the investment banking, retail and custody sectors. Her areas of expertise include business development, structuring, deal negotiation and transaction management. She also has extensive experience in dealing with regulators in multiple jurisdictions.
Sonia holds a Law Degree (LL.B) from the London School of Economics and Political Science (LSE), a Master’s degree (LL.M) in International Trade Law as well as Solicitors’ professional qualifications. She has previously held Customer and Director (plus additional governance) functions under the UK FSA (now FCA) regulatory regime.